EA201691306A1 - Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли - Google Patents

Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли

Info

Publication number
EA201691306A1
EA201691306A1 EA201691306A EA201691306A EA201691306A1 EA 201691306 A1 EA201691306 A1 EA 201691306A1 EA 201691306 A EA201691306 A EA 201691306A EA 201691306 A EA201691306 A EA 201691306A EA 201691306 A1 EA201691306 A1 EA 201691306A1
Authority
EA
Eurasian Patent Office
Prior art keywords
der
allergy
claw
treatment
peptides
Prior art date
Application number
EA201691306A
Other languages
English (en)
Inventor
Клаус Лундегорд
Ларс Хардер Кристенсен
Петер Адлер Вюртцен
Алессандро Сетте
Джон Сидни
Гитте Лунд
Original Assignee
Альк-Абелло А/С
Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Альк-Абелло А/С, Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи filed Critical Альк-Абелло А/С
Publication of EA201691306A1 publication Critical patent/EA201691306A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к комбинациям пептидов или их вариантов, полученных из части аминокислотной последовательности аллергена клеща домашней пыли, например аллергенов Der p 1, Der f 1, Der p 2 и/или Der f 2. Такие пептиды содержат по меньшей мере один Т-клеточный эпитоп, и значительно большое число пациентов в мировой популяции будет иметь аллели HLA с потенциалом связывания с пептидами пептидных комбинаций. Настоящее изобретение также относится к применению таких пептидных комбинаций при ослаблении иммунного ответа, вызываемого пылевыми клещами.
EA201691306A 2013-12-23 2014-12-23 Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли EA201691306A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361919925P 2013-12-23 2013-12-23
US201462012690P 2014-06-16 2014-06-16
PCT/US2014/072228 WO2015100360A1 (en) 2013-12-23 2014-12-23 Peptide combinations and uses thereof in treating dust mite allergy

Publications (1)

Publication Number Publication Date
EA201691306A1 true EA201691306A1 (ru) 2016-10-31

Family

ID=52293308

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691306A EA201691306A1 (ru) 2013-12-23 2014-12-23 Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли

Country Status (12)

Country Link
US (1) US10059751B2 (ru)
EP (1) EP3086806B1 (ru)
JP (1) JP2017507906A (ru)
KR (1) KR20160096206A (ru)
CN (1) CN105848677B (ru)
AU (1) AU2014369866A1 (ru)
BR (1) BR112016011930A2 (ru)
CA (1) CA2933552A1 (ru)
EA (1) EA201691306A1 (ru)
MX (1) MX2016008305A (ru)
SG (1) SG11201604892YA (ru)
WO (1) WO2015100360A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3662916A1 (en) * 2010-06-03 2020-06-10 ALK-Abelló A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
US11013781B2 (en) 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy
US11464839B2 (en) 2015-12-04 2022-10-11 Mayo Foundation For Medical Education And Research Methods and vaccines for inducing immune responses to multiple different MHC molecules
WO2017203057A1 (en) * 2016-05-27 2017-11-30 Alk-Abelló A/S Immunogenic proteins and fragments thereof from allergenic mites
CN108265059B (zh) 2016-12-31 2021-01-05 江苏众红生物工程创药研究院有限公司 一种重组粉尘螨2类变应原蛋白及其制备方法与应用
CN107338261B (zh) * 2017-07-17 2023-04-07 海南大学 热带无爪螨重组变应原Blot5-21、其制备方法及过敏小鼠模型的建立
KR20210151822A (ko) * 2019-03-14 2021-12-14 엔진 인코포레이티드 키토산-핵산 나노입자의 가역성 코팅 및 이의 사용 방법
CN113125753B (zh) * 2021-04-16 2022-07-26 杭州浙大迪迅生物基因工程有限公司 一种用于检测尘螨组分特异性抗体的试剂盒

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US7288256B1 (en) * 1991-10-16 2007-10-30 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides (house dust mite)
PT100978B (pt) 1991-10-16 1999-10-29 Immulogic Pharma Corp Peptidos recombitope, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem, processo para a sua concepcao e sue uso.
NZ284637A (en) 1994-04-14 1998-09-24 Immulogic Pharma Corp Pharmaceutical formulations for treating dust mite allergy
US5820862A (en) * 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
JP2001231563A (ja) * 2000-02-18 2001-08-28 Asahi Breweries Ltd 改変したダニアレルゲン（システイン変異体）及びその製造方法
JP2007511318A (ja) 2003-11-18 2007-05-10 ナノ パス テクノロジーズ リミテッド 改良された挿入システム及びマイクロニードルを摺動させるための方法
EP1819379B1 (en) 2004-11-18 2016-08-31 Nanopass Technologies Ltd. System for delivering fluid into flexible biological barrier
EP2559448B1 (en) 2005-12-08 2017-05-31 Nanopass Technologies Ltd. Microneedle adapter for dosed drug delivery devices
EP2476437B1 (en) * 2006-08-11 2018-11-28 Life Sciences Research Partners VZW Immunogenic peptides and their use in immune disorders
KR101699554B1 (ko) * 2007-08-15 2017-01-25 서카시아 리미티드 백신용 펩티드
EP2331124A1 (en) 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
PT2717910T (pt) 2011-06-09 2019-05-22 Biomay Ag Proteínas de fusão transportadoras de péptido como vacinas para alergia
WO2013061290A1 (en) 2011-10-26 2013-05-02 Nanopass Technologies Ltd. Microneedle intradermal drug delivery device with auto-disable functionality
JP2015509487A (ja) * 2012-02-07 2015-03-30 ラ ホーヤ インスティテュート フォー アレルギー アンド イムノロジーＬａ Ｊｏｌｌａ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ａｌｌｅｒｇｙ Ａｎｄ Ｉｍｍｕｎｏｌｏｇｙ アレルゲンタンパク質由来のエピトープ並びに免疫応答モジュレーションのための方法及び使用
CN104203277A (zh) 2012-02-07 2014-12-10 拉霍拉敏感及免疫学研究所 梯牧草变应原和用于调节免疫反应的方法和用途
US20130302338A1 (en) 2012-05-14 2013-11-14 Promd Biotech. Co., Ltd. Dermatophagoid pteronyssinus (der p1) antigen epitope and anti-der p1 antibody
US20140350514A1 (en) 2013-05-22 2014-11-27 Nanopass Technologies Ltd. Systems and methods for intradermal delivery of therapeutics using microneedles

Also Published As

Publication number Publication date
CN105848677B (zh) 2020-01-31
EP3086806A1 (en) 2016-11-02
CA2933552A1 (en) 2015-07-02
AU2014369866A1 (en) 2016-06-30
CN105848677A (zh) 2016-08-10
US20160251403A1 (en) 2016-09-01
JP2017507906A (ja) 2017-03-23
US10059751B2 (en) 2018-08-28
EP3086806B1 (en) 2019-12-11
SG11201604892YA (en) 2016-07-28
MX2016008305A (es) 2017-01-11
WO2015100360A1 (en) 2015-07-02
KR20160096206A (ko) 2016-08-12
BR112016011930A2 (pt) 2017-09-26

Similar Documents

Publication Publication Date Title
EA201691306A1 (ru) Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли
MA41669A1 (fr) Anticorps se liant a tau
AR125326A2 (es) Composiciones de neisseria meningitidis y métodos de las mismas
NZ715038A (en) T cell receptors
MX2020010061A (es) Variantes de region fc con union del receptor fc neonatal (fcrn) modificado y metodos de uso.
EA201070271A1 (ru) Пептиды для получения вакцины
UA107212C2 (ru) Модификация мананазы
BR112016012358A2 (pt) peptídios terapêuticos
EA201592264A1 (ru) Композиции, которые индуцируют хелперное действие т-клеток
JP2015514395A5 (ru)
WO2014150877A3 (en) Anti-tau antibodies and methods of use
ES2722773T3 (es) Polipéptidos de fHbp meningocócicos modificados
GB201201511D0 (en) Modified epitopes for boosting CD4+ T-cell responses
IN2014DN08325A (ru)
MX2014009285A (es) Alergenos del fleo de los prados y metodos y usos para la modulacion de respuesta inmune.
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
EA201492068A1 (ru) Гидрохлоридная соль пептида и ее применение в комбинации с другими пептидами в иммунотерапии
PH12015501033A1 (en) Peptides
MY193724A (en) Immune modulation
WO2015043566A8 (de) Zyklische, amyloid-beta-bindende peptide und deren verwendung
MY167069A (en) Antigen peptide and use thereof
MX2020012569A (es) Moleculas inmunoterapeuticas novedosas y sus usos.
NZ709983A (en) Nutritional compositions containing a peptide component and uses thereof
WO2013006050A9 (en) Peptides inducing or enhancing an immune response against prostate-specific membrane protein (psma)
EA201171430A1 (ru) Пептиды